TMEM236

Across TCGA pan-cancer cohorts, TMEM236 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated TMEM236 data layer compared with 26 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher TMEM236 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated TMEM236 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC and OV are the cancer types where TMEM236 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	II,III,IV	0.940	0.431	.009	28	view →
OV	OS	Median	II,III,IV	0.323	0.843	.001	18	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

TMEM236–UCEC (DFS)

Open the UCEC breakdown →